Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Immuneering Corp shares valued at $10,874 were purchased by HAUSMAN DIANA on Jul 02 ’25. At $3.62 per share, HAUSMAN DIANA acquired 3,000 shares. The insider’s holdings grew to 3,000 shares worth approximately $11880.0 following the completion of this transaction.
Also, HAUSMAN DIANA purchased 2,500 shares, netting a total of over 8,989 in proceeds. Following the buying of shares at $3.60 each, the insider now holds 2,500 shares.
Before that, Neufeld Leah R had added 700 shares to its account. In a trade valued at $2,499, the CHIEF PEOPLE OFFICER bought Immuneering Corp shares for $3.57 each. Upon closing the transaction, the insider’s holdings increased to 700 shares, worth approximately $42486.84.
As published in a research note from Morgan Stanley on December 13, 2024, Immuneering Corp [IMRX] has been rated down from an Equal-weight to an Underweight. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in mid March. As of March 15, 2024, TD Cowen has decreased its “an Outperform” rating to a “Market perform” for IMRX. Earlier on March 15, 2024, Jefferies downgraded its rating. Their new recommendation was “a Hold” for IMRX stock which previously was a “a Buy”.
Analyzing IMRX Stock Performance
On last trading session,, Immuneering Corp [NASDAQ: IMRX] plunged -5.26% to $3.96. The stock’s lowest price that day was $3.82, but it reached a high of $4.1602 in the same session. During the last five days, there has been a drop of approximately -11.01%. Over the course of the year, Immuneering Corp shares have jumped approximately 219.35%. Shares of the company reached a 52-week high of $4.60 on 07/09/25 and a 52-week low of $1.10 on 05/12/25.
Support And Resistance Levels for Immuneering Corp (IMRX)
According to the 24-hour chart, there is a support level at 3.80, which, if violated, would cause prices to drop to 3.63. In the upper region, resistance lies at 4.15. The next price resistance is at 4.33. RSI (Relative Strength Index) is 62.85 on the 14-day chart, showing neutral technical sentiment.
Is Immuneering Corp subject to short interest?
Stocks of Immuneering Corp saw a sharp rise in short interest on 2025-06-13 jumping by 0.23 million shares to 0.89 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 0.66 million shares. A jump of 26.07% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.13 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.13.
Which companies own the most shares of Immuneering Corp (IMRX)?
In terms of Immuneering Corp share price expectations, FactSet research, analysts set an average price target of 13 in the next 12 months, up nearly 211.0% from the previous closing price of $4.18. Analysts anticipate Immuneering Corp stock to reach 41 by 2025, with the lowest price target being 3. In spite of this, 3 analysts ranked Immuneering Corp stock as Buy at the end of 2025. On December 01, 2023, Needham assigned a price target of “a Buy” to the stock and initiated coverage with a $20.
